SCHEMBL4741247

SCHEMBL4741247

CC(C)Oc1ccc(Oc2ccc(C=O)s2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.51
KMT2A Q03164 3/20 0.39
ACACB O00763 6/20 0.38
ACACA Q13085 5/20 0.38
CYP2C9 P11712 2/20 0.38
GLA P06280 1/20 0.38
CYP2C19 P33261 1/20 0.38
PARP10 Q53GL7 1/20 0.38
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP14 P50281 1/20 0.37
PNLIP P16233 1/20 0.37
ERN1 O75460 1/20 0.36
POLB P06746 1/20 0.36
LMNA P02545 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
BRD4 O60885 1/20 0.34
BRPF1 P55201 1/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16894427 0.83 ALDH1A3 (0.42) ALDH1A3CYP2C9GLACYP2C19POLB
SCHEMBL9050215 0.81 ALDH1A1 (0.47) KMT2ACYP2C9CYP2C19PARP10MMP2
SCHEMBL510781 0.81 PPARG (0.44) KMT2ACYP2C9CYP2C19POLBLMNA
SCHEMBL509618 0.78 GAA (0.42) KMT2ACYP2C19MMP2MMP9MMP14
SCHEMBL1106849 0.78 LMNA (0.44) KMT2ACYP2C9CYP2C19POLBLMNA
SCHEMBL31356847 0.74 EPHX2 (0.40) KMT2AMMP2MMP9MMP14LMNA
SCHEMBL9047141 0.74 PPARG (0.30)
SCHEMBL18626699 0.74 CA1 (0.38) ALDH1A1
SCHEMBL4963725 0.74 KDM4E (0.44) KMT2APARP10MMP2MMP3POLB
SCHEMBL5423741 0.74 ACACB (0.61) ALDH1A3ACACBACACACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748627-B2 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome ABBVIE INC. (US) 2014-06-10 US disclosed
EP-1999119-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME Abbott Laboratories (US) 2008-12-10 EP disclosed
WO-2007095602-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2007-08-23 WO disclosed